Schedule 13G ownership disclosure
GW PHARMACEUTICALS PLC
Security class unavailable · CUSIP: 36197T103
Event date: 2015-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 19,832,401
- Percent of class
- 7.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000858744-16-000038
- Form type
- SC 13G
- Filer
- GW PHARMACEUTICALS PLC
- CIK
- CIK 1351288
- Filed
- Feb 16, 2016
- Reporting period
- Dec 31, 2015
- Description
- Schedule 13G beneficial ownership